These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 4200420

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J, Haupt E, Cordes U, Kutschera J, Schöffling K.
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF.
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [Abstract] [Full Text] [Related]

  • 6. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
    Loubatières AL, Loubatieres-Mariani MM, Alric R, Ribes G, Sorial G, Tarasco A.
    Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
    [Abstract] [Full Text] [Related]

  • 7. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
    Gregorio F, Ambrosi F, Filipponi P, Cristallini S, Santeusanio F.
    J Diabetes Complications; 1994 Mar; 8(4):204-12. PubMed ID: 7833495
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A, Mariani MM, Ribes G, de Malbosc H, Alric R, Chapal J.
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL, Ribes G, Loubatières-Mariani MM.
    C R Seances Soc Biol Fil; 1972 Aug; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological study of a new hypoglycaemic sulphonamide: glisoxepid (RP 22410).
    Loubatières A, Mariani MM, Ribes G, Alric R, Agot H.
    Diabetologia; 1972 Feb; 8(1):29-36. PubMed ID: 4554823
    [No Abstract] [Full Text] [Related]

  • 11. [Insulin and pro-insulin secretion following intravenous administration of tolbutamide, glisoxepide and glibenclamide].
    Hausmann L, Schumann G, Kaffarnik H.
    Arzneimittelforschung; 1978 Feb; 28(1):83-6. PubMed ID: 415745
    [Abstract] [Full Text] [Related]

  • 12. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB.
    Horm Res; 1974 Feb; 5(4):211-6. PubMed ID: 4210148
    [No Abstract] [Full Text] [Related]

  • 13. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract] [Full Text] [Related]

  • 14. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J, Haupt E, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract] [Full Text] [Related]

  • 15. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
    Krause U, Puchinger H, Wacker A.
    Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
    [Abstract] [Full Text] [Related]

  • 16. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
    Jorgensen KD.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
    [Abstract] [Full Text] [Related]

  • 17. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A, Mariani MM, Ribes G, Chapal J.
    C R Seances Soc Biol Fil; 1971 Feb; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract] [Full Text] [Related]

  • 18. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG, Hasselblatt A.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
    [Abstract] [Full Text] [Related]

  • 19. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A.
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D, Abbiati R, Orsini G, Parenti MA, Bloch K, Daturi S, Mandelli V.
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.